ARCHIVES

NCAB Study Core Guideline Revisions; Final Decision To Await New Division BSC

This article is from The Cancer Letter archive.

Vol. 06 No. 21 | May 23, 1980

Download PDF Visit The Full Archive

Related Articles

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

September 20, 2013

Zerhouni Announces Changes To NIH Peer Review.

June 6, 2008

In Brief: Sartorelli Replaces Cole As Director Of Yale Comprehensive Center; NSABP Ends Segmental Trials

March 2, 1984

Society Support Program for Training Cytotechnologists

November 29, 1991

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992

In Brief: ACOS Analysis Finds Conclusive Shift To Modified Radical, Earlier Detection, Treatment For Blacks

September 4, 1981